Delivery Order SPE2DB22D9206-SPE2DB24FV5CT

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $2,441.26 order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product. The delivery order was issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract SPE2DB with DLA, which enables the agency to place orders for a broad range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,098.40 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, with a completion date of June 18, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,979.40 order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription drug. This delivery order is placed under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract SPE2DB with DLA, which allows the agency to issue firm fixed-price orders for a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,043.48 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, with a completion date of May 22, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,441.26 contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a prescription insulin product. This delivery order is part of a larger indefinite delivery contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with the Defense Logistics Agency to provide a broad...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,336.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a specialized medication, with a period of performance ending on December 10, 2024. This award is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
The U.S. Defense Logistics Agency has awarded a $9,897.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. DMS Pharmaceutical Group will provide Lantus SoloStar 100 Unit/mL 3mL syringes to the agency. This delivery order is issued against DMS Pharmaceutical Group's existing indefinite delivery contract, SPE2DB, with a potential value of up to $4,999,999 to supply a broad range of pharmaceutical products to military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,098.40 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a prescription medication used for the treatment of diabetes. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned...
This is a delivery order contract with a firm fixed price of $1,581.89 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The $1,675.78 firm-fixed price contract has an ultimate completion date of August 23, 2024. This order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
  • SPE2DB22D9206
    Indefinite Delivery Contract
  • SPE2DB22D9206-SPE2DB24FV5CT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) under contract SPE2DB22D9206 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $2,639.20 firm fixed-price order is for the pharmaceutical product LANTUS SOLOSTAR 100 UNIT/ML 3ML. The delivery order has a completion date of March 19, 2024. DMS Pharmaceutical Group holds an indefinite delivery vehicle (IDV) contract SPE2DB24FV5CT with DLA valued up to $4,999,999 through 2025, enabling the agency to issue delivery orders for a broad range of pharmaceutical items to support military medical facilities worldwide. This contract does not have a set-aside designation.

Generated 6/17/24, 9:26 AM